ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESI....FIRO..CY..TRBGCZEEHU..SK....................................*JDIM360 Ver 2.15 (14 Jul 2008) - 2999001/01542609CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120130220W172 73deBibliographieenBibliographyfrBibliographieEP03749229.5200308292005032420101124enenen407492 P20020829US2013022020130820050622200525201211142012462012051620130220201308A61K 38/21 20060101AFI20120416BHEP A61K 39/00 20060101ALI20120416BHEP A61K 35/00 20060101ALI20120416BHEP A61P 35/00 20060101ALI20120416BHEP deZusammensetzungen enthaltend Beta-Interferon zur Verwendung bei der Behandlung des MelanomsenPharmaceutical compositions comprising Interferon beta for use in treating melanomafrCompositions comprenant l'Interféron bêta pour leur utilisation dans le traitement du mélanomeEP-A1- 0 536 520EP-A2- 0 835 661US-A- 4 737 462US-A1- 2001 042 551US-B1- 6 710 086MAKOTO ODAKA ET AL: "Eradication of Intraperitoneal and Distant Tumor by Adenovirus-mediated Interferon-ß Gene Therapy Is Attributable to Induction of Systemic Immunity" CANCER RESEARCH, vol. 61, 15 August 2001 (2001-08-15), pages 6201-6212, XP002586103ZHONGYUN DONG ET AL.: "Suppression of Angiogenesis, Tumorigenicity, and Metastasis by Human Prostate Cancer Cells Engineered to Produce Interferon-ß" CANCER RESEARCH, vol. 59, 10 February 1999 (1999-02-10), pages 872-879, XP002586104JOHN J. RINEHART ET AL.: "Phase I/II Trial of Interferon-ß-Serine in Patients with Renal Cell Carcinoma; Immunological and Biological Effects" CANCER RESEARCH, vol. 47, 1 May 1987 (1987-05-01), pages 2481-2485, XP002586105SENSI MARIALUISA ET AL: "Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES (PNAS), NATIONAL ACADEMY OF SCIENCE, US LNKD- DOI:10.1073/PNAS.92.12.5674, vol. 92, no. 12, 1 January 1995 (1995-01-01), pages 5674-5678, XP002143225 ISSN: 0027-8424KAWAKAMI Y ET AL: "CLONING OF THE GENE CODING FOR A SHARED HUMAN MELANOMA ANTIGEN RECOGNIZED BY AUTOLOGOUS T CELLS INFILTRATING INTO TUMOR" PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES (PNAS), NATIONAL ACADEMY OF SCIENCE, US LNKD- DOI:10.1073/PNAS.91.9.3515, vol. 91, no. 9, 26 April 1994 (1994-04-26) , pages 3515-3519, XP000770221 ISSN: 0027-8424MATEO ET AL: "An HLA-A2 polyepitope vaccine for melanoma immunotherapy" J IMMUNOL., vol. 7, no. 1, October 1999 (1999-10), pages 4058-4063, XP002587571BROUWENSTIJN N ET AL.: "Transcription of the gene encoding melanoma-associated antigen gp100 in tissues and cell lines other than those of the melanocytic lineage." BR J CANCER, vol. 12, 1997, pages 1562-1566, XP002587572MASCI PAUL ET AL: "Malignant melanoma: treatments emerging, but early detection is still key.", CLEVELAND CLINIC JOURNAL OF MEDICINE JUL 2002 LNKD- PUBMED:12109636, vol. 69, no. 7, July 2002 (2002-07), pages 529 , 533-534 , 536, ISSN: 0891-1150SMITS A: "Low-grade gliomas: clinical and pathobiological aspects.", HISTOLOGY AND HISTOPATHOLOGY JAN 2002 LNKD- PUBMED:11813876, vol. 17, no. 1, January 2002 (2002-01), pages 253-260, ISSN: 0213-391120100708DURDA, Paul, J.149 Laurel DriveNeedham, MA 02492-3206USKURNICK, James, T.58 Post Island RoadQuincy, MA 02169USDunn, Ian, S.28 Waterloo Road, North Epping 2121Sydney, New South WalesAUCytoCure LLC101353256L 1313 EP100 Cummings Center, Suite 430CBeverly, MA 01915USVossius & Partner100751388Siebertstrasse 481675 MünchenDEATBEBGCHCYCZDEDKEEESFIFRGBGRHUIEITLILUMCNLPTROSESISKTRUS200302712520030829enWO200401988620040311200411